Peripheral Arterial Occlusive Disease clinical trials

Explore recruiting peripheral arterial occlusive disease clinical trials.

Recruiting peripheral arterial occlusive disease studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Peripheral Arterial Occlusive Disease trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Safety, tolerability, and biodistribution of [89Zr]Zr-DFO-APAC (Phase 0) in subjects with peripheral arterial occlusive disease / critical limb ischemia (PAOD/CLI) and healthy volunteers – an open label PET study (CHASE-study)

Netherlands

Human Pharmacology (Phase I)- Other EU CTIS Study details

A phase 2a open-label study to assess the safety, tolerability, and dosing regimen of antithrombotic heparin proteoglycan mimetic APAC (antiplatelet, anticoagulant) in patients with peripheral arterial occlusive disease and chronic limb-threatening ischemia undergoing endovascular revascularization (HEALING -study)

Finland

Therapeutic exploratory (Phase II) EU CTIS Study details

Duration of Dual Anti-Platelet Therapy in Chronic Limb Threatening Ischemia after Distal Revascularization: a randomized, double-blind trial PALADIN [PeripherAL Arterial DIsease Network] -DAPTCLTI

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Peripheral Arterial Occlusive Disease trials by city

Peripheral Arterial Occlusive Disease in Toronto Peripheral Arterial Occlusive Disease in Vancouver Peripheral Arterial Occlusive Disease in Montreal Peripheral Arterial Occlusive Disease in Calgary Peripheral Arterial Occlusive Disease in Edmonton Peripheral Arterial Occlusive Disease in Ottawa Peripheral Arterial Occlusive Disease in Winnipeg Peripheral Arterial Occlusive Disease in Quebec City Peripheral Arterial Occlusive Disease in Hamilton Peripheral Arterial Occlusive Disease in Kitchener Peripheral Arterial Occlusive Disease in London Peripheral Arterial Occlusive Disease in Halifax Peripheral Arterial Occlusive Disease in New York Peripheral Arterial Occlusive Disease in Los Angeles Peripheral Arterial Occlusive Disease in Chicago Peripheral Arterial Occlusive Disease in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease